News & Articles

Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Discover how scientists at Medicine Discovery Catapult are using biomarkers to tailor approaches to patient care, in this exclusive interview with Dr. Sally Price

Research led by the University of Edinburgh has developed new data analysis tool in a bid to improve disease progression research

Find out how two distinct single-cell RNA-seq approaches were used to create a large-scale Cell Atlas, with this on-demand expert webinar

Understanding how insects navigate using the sun and daylight has potential to aid robot guidance system development

Join this expert webinar to find out how two distinct technical approaches were used to collect single-cell transcriptomic data from the Mus musculus model

This new range of kits is said to deliver high-quality ChIP-ready chromatin from as little as 5 Drosophila specimens

A study from the University of Cambridge highlights potential new treatment for neurodegeneration

Immunology-focused pharma company INmune Bio is set to start first-in-man clinical trials with a promising anti-TNF compound that could revolutionize the treatment of Alzheimer’s disease and related symptoms

Research shows it is now possible to predict what action will be chosen next – the risk or the safe option – based on neuronal activity

New technology enables production of biologically relevant cells to create human models for drug development

The findings could help clinicians decide the best course and delivery of treatment for cancer patients

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

Significant impact on mice survival and skin graft rejection vs. control in relevant GvHD and skin transplant models

How a researcher at UC San Diego is elucidating the role of microglial dysfunction in brain trauma and disorders

Salk researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer’s disease

Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research

Medical Research Council study explains how the manufacturing material, used in everything from sports equipment to aircraft, could cause deadly mesothelioma

Innovative and relevant models for understanding alpha-synuclein biology and Parkinson’s disease pathogenesis in vivo

Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag, research suggests